Bank of New Hampshire’s Novartis NVS Stock Holding History

Bank of New Hampshire’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$40K	Hold	255	–	–	0.01%	345
2026 Q1	$39K	Hold	255	–	–	0.01%	339
2025 Q4	$35.2K	Hold	255	–	–	0.01%	320
2025 Q3	$32.7K	Hold	255	–	–	0.01%	320
2025 Q2	$30.9K	Hold	255	–	–	0.01%	321
2025 Q1	$28.4K	Hold	255	–	–	0.01%	319
2024 Q4	$24.8K	Hold	255	–	–	0.01%	334
2024 Q3	$29.3K	Hold	255	–	–	0.01%	329
2024 Q2	$27.1K	Hold	255	–	–	0.01%	347
2024 Q1	$24.7K	Hold	255	–	–	0.01%	364
2023 Q4	$25.7K	Hold	255	–	–	0.01%	357
2023 Q3	$26K	Hold	255	–	–	0.01%	353
2023 Q2	$25.7K	Hold	255	–	–	0.01%	365
2023 Q1	$23.5K	Sell	255 -15	-6%	-$1.31K	0.01%	365
2022 Q4	$24K	Hold	270	–	–	0.01%	373
2022 Q3	$21K	Buy	270 +115	+74%	+$9.53K	0.01%	385
2022 Q2	$13K	Hold	155	–	–	﹤0.01%	442
2022 Q1	$14K	Buy	+155	New	+$13.4K	﹤0.01%	450

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

NewEdge Wealth Pittsburgh, Pennsylvania $10B AUM 30.45% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

AGF Management Toronto, Ontario, Canada $25.8B AUM 56.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Bank of New Hampshire's NVS Position: Q2 2026 in Review

Bank of New Hampshire held its Novartis (NVS) position steady in Q2 2026 at 255 shares worth $40K. The position accounts for 0.01% of the portfolio, ranked #345.

Bank of New Hampshire first reported a position in NVS in Q1 2022 and has held it in 18 quarters since. 1,094 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

Bank of New Hampshire held 255 shares of Novartis worth $40K as of Q2 2026.
Bank of New Hampshire left its Novartis share count unchanged in Q2 2026.
Novartis made up 0.01% of Bank of New Hampshire's portfolio in Q2 2026, its #345 holding.
Bank of New Hampshire first reported a position in Novartis in Q1 2022 and has held it in 18 quarters since.
1,094 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Bank of New Hampshire's 13F filing for Q2 2026, filed 14 Jul 2026.